Inventor · disambiguated record
Michela Gallagher
Also filed as: GALLAGHER MICHELA
7 granted patents·26 pending applications·29 citations·filing 2003–2024
82Inventor score
Top patents by PatentIndex Score
33 records- 0188US8510055B2Methods for characterizing and treating cognitive impairment in aging and diseaseGALLAGHER MICHELA·Filed 2006·Granted Aug 13, 2013·11 cites·3 claims
- 0284US8604075B2Methods and compositions for improving cognitive functionGALLAGHER MICHELA·Filed 2011·Granted Dec 10, 2013·10 cites·18 claims
- 0383US10925834B2Extended release pharmaceutical compositions of levetiracetamAGENEBIO INC·Filed 2016·Granted Feb 23, 2021·2 cites·14 claims
- 0481US10624875B2Methods and compositions for treating schizophreniaUNIV JOHNS HOPKINS·Filed 2017·Granted Apr 21, 2020·2 cites·11 claims
- 0580US2024293363A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 0678US10154988B2Methods and compositions for treating schizophreniaUNIV JOHNS HOPKINS·Filed 2013·Granted Dec 18, 2018·4 cites·7 claims
- 0773US2023172862A1Extended release pharmaceutical compositions of levetiracetamAGENEBIO INC·Filed 2022·Application pending·0 cites
- 0871US2022218665A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 0970US2023277501A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1067US2022265685A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1166US2021346299A1Extended release pharmaceutical compositions of levetiracetamAGENEBIO INC·Filed 2020·Application pending·0 cites
- 1263US10806717B2Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2014·Granted Oct 20, 2020·0 cites·3 claims
- 1363US2023270753A1Combinations of gabaa alpha 5 agonists and sv2a inhibitors and methods of using in the treatment of cognitive impairmentAGENEBIO INC·Filed 2021·Application pending·0 cites
- 1463US2023033195A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1563US2022062296A1Combinations of gabaa alpha 5 agonists and sv2a inhibitors and methods of using in the treatment of cognitive impairmentAGENEBIO INC·Filed 2021·Application pending·0 cites
- 1662US2010099735A1Methods and compositions for improving cognitive functionGALLAGHER MICHELA·Filed 2009·Application pending·0 cites
- 1762US2014057903A1Methods for characterizing and treating cognitive impairment in aging and diseaseUNIV JOHNS HOPKINS·Filed 2013·Application pending·0 cites
- 1859US2021244709A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1959US2025228820A1Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performanceAGENEBIO INC·Filed 2023·Application pending·0 cites
- 2058US2018010183A1Methods for characterizing and treating cognitive impairment in aging and diseaseUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 2158US2015094352A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 2257US2024238246A1Methods for preventing or slowing the progression of cognitive decline or impairment in subjectsAGENEBIO INC·Filed 2024·Application pending·0 cites
- 2354US10159648B2Extended release pharmaceutical compositions of levetiracetamAGENEBIO INC·Filed 2016·Granted Dec 25, 2018·0 cites·25 claims
- 2452US2008177061A1Target for therapy of cognitive impairmentGALLAGHER MICHELA·Filed 2008·Application pending·0 cites
- 2548US2018015109A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 2647US2004191803A1Target for therapy of cognitive impairmentFiled 2003·Application pending·0 cites
- 2747US2005267077A1Method for improving cognitive function by co-administration of a GABAB receptor antagonist and an acetylcholinesterase inhibitorUNIV JOHNS HOPKINS·Filed 2005·Application pending·0 cites
- 2847US2011065674A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 2947US2005267076A1Method for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2005·Application pending·0 cites
- 3046US2011212928A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2011·Application pending·0 cites
- 3146US2006014801A1Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogsUNIV JOHNS HOPKINS·Filed 2005·Application pending·0 cites
- 3242US2012214859A1Methods and compositions for improving cognitive functionGALLAGHER MICHELA·Filed 2012·Application pending·0 cites
- 3338US2016030391A1Methods and compositions for improving cognitive functionUNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michela Gallagher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →